EP11.03. Platinum/Taxane versus Docetaxel +/- Ramucirumab for Metastatic Lung Cancers That Progressed on Platinum Doublets and Anti-PD1/PD-L1 - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Kang Qin
Meta Tag
Speaker Kang Qin
Topic Metastatic NSCLC: Immunotherapy - Retrospective
Keywords
metastatic non-small cell lung cancer
NSCLC
treatment options
platinum-based doublets
immune checkpoint blockade
Docetaxel
Ramucirumab
cancer gene mutation status
platinum-taxane regimens
clinical benefit
Powered By